Global Molecular Point-of-Care Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Molecular Point-of-Care Testing market size was valued at US$ 8328 million in 2025 and is forecast to a readjusted size of US$ 11360 million by 2032 with a CAGR of 4.6% during review period.
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
The global molecular point-of-care testing (POCT) market refers to the market for diagnostic tests that can be performed at or near the point of patient care, providing rapid and accurate results for a wide range of diseases and conditions. Molecular POCT involves the use of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), to detect and identify specific genetic material or biomarkers associated with diseases or infections.
Here are some key factors influencing the growth of the global molecular POCT market:
Increasing demand for rapid and accurate diagnostic testing: The need for rapid and accurate diagnostic testing is driving the growth of the molecular POCT market. Molecular POCT offers advantages such as rapid turnaround time, portability, and the ability to provide accurate results at the point of care, eliminating the need for sample transportation to centralized laboratories. This is particularly beneficial in emergency and critical care settings, where timely diagnosis is crucial for effective patient management.
Technological advancements in molecular diagnostics: Molecular diagnostic technologies have witnessed significant advancements in recent years, enabling the development of portable, user-friendly, and easy-to-operate molecular POCT devices. These devices offer rapid and reliable results, making them suitable for use in various healthcare settings, including hospitals, clinics, ambulatory care centers, and remote or resource-limited areas. Technological advancements continue to drive the growth of the molecular POCT market.
Rising prevalence of infectious diseases: The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections (STIs), and gastrointestinal infections, remains significant. Molecular POCT plays a crucial role in the rapid detection and identification of pathogens responsible for these infections. The increasing prevalence of infectious diseases, coupled with the need for early diagnosis and treatment, is boosting the demand for molecular POCT solutions.
Growing focus on personalized medicine: Personalized medicine aims to tailor medical treatments to individual patients based on their genetic makeup, lifestyle, and other factors. Molecular POCT plays a vital role in enabling personalized medicine by providing rapid and accurate genetic testing at the point of care. These tests help identify genetic variations, mutations, or biomarkers that can guide treatment decisions and improve patient outcomes. The growing focus on personalized medicine is driving the adoption of molecular POCT.
COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly accelerated the demand for molecular POCT. Rapid and accurate testing for SARS-CoV-2, the virus responsible for COVID-19, has been crucial in controlling the spread of the disease and managing patient care effectively. Molecular POCT devices, such as rapid antigen tests and molecular NAATs, have been widely used for COVID-19 testing in various healthcare settings.
The global molecular POCT market can be segmented based on technology (PCR, NAATs, hybridization, and others), application (infectious diseases, oncology, genetics, and others), end-user (hospitals, clinics, ambulatory care centers, research institutes, and others), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).
In summary, the global molecular POCT market is driven by the increasing demand for rapid and accurate diagnostic testing, technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, the growing focus on personalized medicine, and the impact of the COVID-19 pandemic. Molecular POCT offers the advantage of providing rapid and accurate results at the point of care, enabling timely and appropriate patient management. The market is expected to witness significant growth as the demand for portable and user-friendly molecular diagnostic solutions continues to rise.
This report is a detailed and comprehensive analysis for global Molecular Point-of-Care Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Point-of-Care Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Molecular Point-of-Care Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Molecular Point-of-Care Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Molecular Point-of-Care Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Point-of-Care Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Point-of-Care Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Molecular Diagnostics, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, bioMérieux, Inc., Hologic, Inc., Meridian Bioscience, Inc., Saw Diagnostics, Siemens Healthineer, Sona Nanotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Point-of-Care Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
Market segment by Application
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Market segment by players, this report covers
Roche Molecular Diagnostics
Roche Diagnostics
Abbott Laboratories
Danaher Corporation
bioMérieux, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Point-of-Care Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Point-of-Care Testing, with revenue, gross margin, and global market share of Molecular Point-of-Care Testing from 2021 to 2026.
Chapter 3, the Molecular Point-of-Care Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Molecular Point-of-Care Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Point-of-Care Testing.
Chapter 13, to describe Molecular Point-of-Care Testing research findings and conclusion.
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
The global molecular point-of-care testing (POCT) market refers to the market for diagnostic tests that can be performed at or near the point of patient care, providing rapid and accurate results for a wide range of diseases and conditions. Molecular POCT involves the use of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), to detect and identify specific genetic material or biomarkers associated with diseases or infections.
Here are some key factors influencing the growth of the global molecular POCT market:
Increasing demand for rapid and accurate diagnostic testing: The need for rapid and accurate diagnostic testing is driving the growth of the molecular POCT market. Molecular POCT offers advantages such as rapid turnaround time, portability, and the ability to provide accurate results at the point of care, eliminating the need for sample transportation to centralized laboratories. This is particularly beneficial in emergency and critical care settings, where timely diagnosis is crucial for effective patient management.
Technological advancements in molecular diagnostics: Molecular diagnostic technologies have witnessed significant advancements in recent years, enabling the development of portable, user-friendly, and easy-to-operate molecular POCT devices. These devices offer rapid and reliable results, making them suitable for use in various healthcare settings, including hospitals, clinics, ambulatory care centers, and remote or resource-limited areas. Technological advancements continue to drive the growth of the molecular POCT market.
Rising prevalence of infectious diseases: The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections (STIs), and gastrointestinal infections, remains significant. Molecular POCT plays a crucial role in the rapid detection and identification of pathogens responsible for these infections. The increasing prevalence of infectious diseases, coupled with the need for early diagnosis and treatment, is boosting the demand for molecular POCT solutions.
Growing focus on personalized medicine: Personalized medicine aims to tailor medical treatments to individual patients based on their genetic makeup, lifestyle, and other factors. Molecular POCT plays a vital role in enabling personalized medicine by providing rapid and accurate genetic testing at the point of care. These tests help identify genetic variations, mutations, or biomarkers that can guide treatment decisions and improve patient outcomes. The growing focus on personalized medicine is driving the adoption of molecular POCT.
COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly accelerated the demand for molecular POCT. Rapid and accurate testing for SARS-CoV-2, the virus responsible for COVID-19, has been crucial in controlling the spread of the disease and managing patient care effectively. Molecular POCT devices, such as rapid antigen tests and molecular NAATs, have been widely used for COVID-19 testing in various healthcare settings.
The global molecular POCT market can be segmented based on technology (PCR, NAATs, hybridization, and others), application (infectious diseases, oncology, genetics, and others), end-user (hospitals, clinics, ambulatory care centers, research institutes, and others), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).
In summary, the global molecular POCT market is driven by the increasing demand for rapid and accurate diagnostic testing, technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, the growing focus on personalized medicine, and the impact of the COVID-19 pandemic. Molecular POCT offers the advantage of providing rapid and accurate results at the point of care, enabling timely and appropriate patient management. The market is expected to witness significant growth as the demand for portable and user-friendly molecular diagnostic solutions continues to rise.
This report is a detailed and comprehensive analysis for global Molecular Point-of-Care Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Point-of-Care Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Molecular Point-of-Care Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Molecular Point-of-Care Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Molecular Point-of-Care Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Point-of-Care Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Point-of-Care Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Molecular Diagnostics, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, bioMérieux, Inc., Hologic, Inc., Meridian Bioscience, Inc., Saw Diagnostics, Siemens Healthineer, Sona Nanotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Point-of-Care Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
Market segment by Application
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Market segment by players, this report covers
Roche Molecular Diagnostics
Roche Diagnostics
Abbott Laboratories
Danaher Corporation
bioMérieux, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Point-of-Care Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Point-of-Care Testing, with revenue, gross margin, and global market share of Molecular Point-of-Care Testing from 2021 to 2026.
Chapter 3, the Molecular Point-of-Care Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Molecular Point-of-Care Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Point-of-Care Testing.
Chapter 13, to describe Molecular Point-of-Care Testing research findings and conclusion.
Table of Contents
131 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
